Liver abnormalities in pulmonary arterial hypertension

1. Simonneau, G, Montani, D, Celermajer, DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913.
Google Scholar2. Nickel, NP, Yuan, K, Dorfmuller, P, et al. Beyond the lungs: systemic manifestations of pulmonary arterial hypertension. Am J Respir Crit Care Med 2020; 201: 148–157.
Google Scholar | Crossref | Medline3. Rosenkranz, S, Howard, LS, Gomberg-Maitland, M, et al. Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 2020; 141: 678–693.
Google Scholar | Crossref | Medline4. Gao, F, Cai, MX, Lin, MT, et al. Model for end-stage liver disease and pneumonia: an improved scoring model for critically ill cirrhotic patients with pneumonia. Turk J Gastroenterol 2019; 30: 532–540.
Google Scholar | Crossref | Medline5. Koksal, D, Koksal, AS, Gurakar, A. Pulmonary manifestations among patients with primary biliary cirrhosis. J Clin Transl Hepatol 2016; 4: 258–262.
Google Scholar | Medline6. Bofarid, S, Hosman, AE, Mager, JJ, et al. Pulmonary vascular complications in hereditary hemorrhagic telangiectasia and the underlying pathophysiology. Int J Mol Sci 2021; 22: 3471.
Google Scholar | Crossref | Medline7. Kavarana, MN, Jones, JA, Stroud, RE, et al. Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications. Expert Rev Cardiovasc Ther 2014; 12: 703–713.
Google Scholar | Crossref | Medline8. Hoeper, MM, Krowka, MJ, Strassburg, CP. Portopulmonary hypertension and hepatopulmonary syndrome. The Lancet 2004; 363: 1461–1468.
Google Scholar | Crossref | Medline | ISI9. Lightsey, JM, Rockey, DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol 2017; 33: 158–163.
Google Scholar | Crossref | Medline10. Hilscher, M, Sanchez, W. Congestive hepatopathy. Clin Liver Dis (Hoboken) 2016; 8: 68–71.
Google Scholar | Crossref | Medline11. Eipel, C, Abshagen, K, Vollmar, B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16: 6046–6057.
Google Scholar | Crossref | Medline | ISI12. Samsky, MD, Patel, CB, DeWald, TA, et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol 2013; 61: 2397–2405.
Google Scholar | Crossref | Medline | ISI13. Arques, S, Roux, E, Sbragia, P, et al. Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. Int J Cardiol 2008; 125: 265–267.
Google Scholar | Crossref | Medline14. Ambrosy, AP, Pang, PS, Khan, S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 2013; 34: 835–843.
Google Scholar | Crossref | Medline15. van Deursen, VM, Damman, K, Hillege, HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 2010; 16: 84–90.
Google Scholar | Crossref | Medline | ISI16. Yokoda, RT, Rodriguez, EA. Review: pathogenesis of cholestatic liver diseases. World J Hepatol 2020; 12: 423–435.
Google Scholar | Crossref | Medline17. Allen, LA, Felker, GM, Pocock, S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009; 11: 170–177.
Google Scholar | Crossref | Medline | ISI18. Poelzl, G, Ess, M, Mussner-Seeber, C, et al. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest 2012; 42: 153–163.
Google Scholar | Crossref | Medline | ISI19. Goyal, P, Almarzooq, ZI, Horn, EM, et al. Characteristics of hospitalizations for heart failure with preserved ejection fraction. Am J Med 2016; 129: 635.e15–635.e26.
Google Scholar | Crossref20. Lau, GT, Tan, HC, Kritharides, L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002; 90: 1405–1409.
Google Scholar | Crossref | Medline21. Dalos, D, Binder, C, Duca, F, et al. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction. Sci Rep 2019; 9: 18541.
Google Scholar | Crossref | Medline22. Ess, M, Mussner-Seeber, C, Mariacher, S, et al. Gamma-glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure. J Card Fail 2011; 17: 577–584.
Google Scholar | Crossref | Medline23. Scholfield, M, Schabath, MB, Guglin, M. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial. J Card Fail 2014; 20: 476–484.
Google Scholar | Crossref | Medline24. Dichtl, W, Vogel, W, Dunst, KM, et al. Cardiac hepatopathy before and after heart transplantation. Transpl Int 2005; 18: 697–702.
Google Scholar | Crossref | Medline25. Crespo-Leiro, MG, Robles, O, Paniagua, MJ, et al. Reversal of cardiac cirrhosis following orthotopic heart transplantation. Am J Transplant 2008; 8: 1336–1339.
Google Scholar | Crossref | Medline26. Trauner, M, Fickert, P, Stauber, RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol 1999; 14: 946–959.
Google Scholar | Crossref | Medline | ISI27. Horvatits, T, Drolz, A, Trauner, M, et al. Liver injury and failure in critical illness. Hepatology 2019; 70: 2204–2215.
Google Scholar | Crossref | Medline28. Rabinovitch, M, Guignabert, C, Humbert, M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014; 115: 165–175.
Google Scholar | Crossref | Medline | ISI29. Pasini, E, Aquilani, R, Gheorghiade, M, et al. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J 2003; 4: 232–235.
Google Scholar | Medline30. Biegus, J, Hillege, HL, Postmus, D, et al. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. Eur J Heart Fail 2016; 18: 830–839.
Google Scholar | Crossref | Medline31. Adlbrecht, C, Kommata, S, Hulsmann, M, et al. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008; 29: 2343–2350.
Google Scholar | Crossref | Medline32. Chojkier, M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol 2005; 39: S143–S146.
Google Scholar | Crossref | Medline | ISI33. Battin, DL, Ali, S, Shahbaz, AU, et al. Hypoalbuminemia and lymphocytopenia in patients with decompensated biventricular failure. Am J Med Sci 2010; 339: 31–35.
Google Scholar | Crossref | Medline34. Jackson, CE, Solomon, SD, Gerstein, HC, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009; 374: 543–550.
Google Scholar | Crossref | Medline | ISI35. Carr, JG, Stevenson, LW, Walden, JA, et al. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709–713.
Google Scholar | Crossref | Medline | ISI36. Horwich, TB, Kalantar-Zadeh, K, MacLellan, RW, et al. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008; 155: 883–889.
Google Scholar | Crossref | Medline | ISI37. Grodin, JL, Lala, A, Stevens, SR, et al. Clinical Implications of serum albumin levels in acute heart failure: insights from DOSE-AHF and ROSE-AHF. J Card Fail 2016; 22: 884–890.
Google Scholar | Crossref | Medline38. Benza, RL, Miller, DP, Gomberg-Maitland, M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164–172.
Google Scholar | Crossref | Medline | ISI39. Xu, XQ, Lv, ZC, Liu, QQ, et al. Direct bilirubin: a new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol 2017; 228: 895–899.
Google Scholar | Crossref | Medline40. Kawut, SM, Horn, EM, Berekashvili, KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199–203.
Google Scholar | Crossref | Medline | ISI41. Haddad, F, Peterson, T, Fuh, E, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail 2011; 4: 692–699.
Google Scholar | Crossref | Medline | ISI42. Hao, YJ, Jiang, X, Zhou, W, et al. Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J 2014; 44: 963–972.
Google Scholar | Crossref | Medline43. Stepnowska, E, Lewicka, E, Dabrowska-Kugacka, A, et al. Predictors of poor outcome in patients with pulmonary arterial hypertension: a single center study. PLoS One 2018; 13: e0193245.
Google Scholar | Crossref | Medline44. Takeda, Y, Takeda, Y, Tomimoto, S, et al. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med 2010; 10: 22.
Google Scholar | Crossref | Medline | ISI45. Snipelisky, D, Jentzer, J, Batal, O, et al. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension. Clin Cardiol 2018; 41: 782–787.
Google Scholar | Crossref | Medline46. Zhang, YJ, Wang, N, Gu, ZC, et al. A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension. Cardiovasc Diagn Ther 2019; 9: 239–249.
Google Scholar | Crossref | Medline47. Krings, G, Can, B, Ferrell, L. Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease. Am J Surg Pathol 2014; 38: 205–214.
Google Scholar | Crossref | Medline | ISI48. Louie, CY, Pham, MX, Daugherty,

留言 (0)

沒有登入
gif